Lavina Talukdar's most recent trade in Monopar Therapeutics Inc was a trade of 2,924 Stock Options done . Disclosure was reported to the exchange on Dec. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monopar Therapeutics Inc | Lavina Talukdar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2025 | 2,924 | 2,924 | - | - | Stock Options | |
| Monopar Therapeutics Inc | Lavina Talukdar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 5,683 | 5,683 | - | - | Stock Options |